A new HPLC-MS/MS analytical method for quantification of tazobactam, piperacillin, and meropenem in human plasma

J Sep Sci. 2021 Jul;44(14):2744-2753. doi: 10.1002/jssc.202100067. Epub 2021 Jun 15.

Abstract

A simple and fast high-performance liquid chromatography with tandem mass spectrometry method for quantification of tazobactam, piperacillin, and meropenem in human plasma has been developed and validated. Simple sample preparation with a volume of 10 μL was done by protein precipitation with a mixture of methanol-acetonitrile-water (6:2:2, v/v/v). Chromatographic separation was achieved on a Luna column with a precolumn security guard by gradient elution using a mobile phase consisting of water with the addition of 0.1% formic acid (component A) and mixture methanol-acetonitrile (8:2, v/v) with the addition of 0.1% formic acid (component B). The run time was 2.7 min. The lower limits of detection and lower limits of quantification were for piperacillin 0.03 and 0.1 mg/L, for meropenem 0.04 and 0.2 mg/L and for tazobactam 0.16 and 0.5 mg/L. The validated method was used for therapeutic monitoring of tazobactam, piperacillin, and meropenem in samples of patients treated in the intensive care unit.

Keywords: beta-lactam antibiotics; liquid chromatography; tandem mass spectrometry; therapeutic drug monitoring.

MeSH terms

  • Anti-Bacterial Agents / blood*
  • Chromatography, High Pressure Liquid / methods
  • Drug Monitoring / methods*
  • Humans
  • Limit of Detection
  • Meropenem / blood
  • Piperacillin / blood
  • Plasma / chemistry*
  • Reproducibility of Results
  • Tandem Mass Spectrometry / methods
  • Tazobactam / blood
  • beta-Lactamase Inhibitors / blood

Substances

  • Anti-Bacterial Agents
  • beta-Lactamase Inhibitors
  • Meropenem
  • Tazobactam
  • Piperacillin